
McKesson Corporation
MCK · NYSE · Healthcare / Medical Distribution
Price History
Full chartMarket Stats
About
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Company Details
- SectorHealthcare
- IndustryMedical Distribution
- CEOMr. Brian S. Tyler Ph.D.
- Employees41.60K
- Headquarters6555 State Highway 161, Irving, TX, United States, 75039, USA
- Websitehttps://www.mckesson.com
Leadership
- Mr. Brian S. Tyler Ph.D.CEO & Chairman · b. 1967
- Ms. Michele Lau J.D.Executive VP & Chief Legal Officer · b. 1976
- Ms. LeAnn B. SmithExecutive VP & Chief Human Resources Officer · b. 1975
- Mr. Kenny K. CheungExecutive VP & CFO · b. 1982
- Mr. Napoleon B. Rutledge Jr.Senior VP, Controller & Chief Accounting Officer · b. 1973
- Paula AdkisonSenior Vice President of Corporate Finance, Investor Relations & Strategic Finance
- Mr. Francisco J. FragaExecutive VP, Chief Information Officer & CTO · b. 1973
- Ms. Jeni DominguezHead of Investor Relations
- Mr. Kirk KaminskyExecutive VP & Group President of North American Pharmaceutical Services
- Mr. Stanton J. McCombPresident of Medical-Surgical
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy9
- Buy3
- Hold3
Ownership Breakdown
- Institutions
- 93.54%
- Insiders
- 0.06%
- Retail / Other
- 6.40%
Top Institutional Holders
- BlackRock Inc10.80M9.26%
- Vanguard Capital Management, LLC7.85M6.74%
- State Street Corp5.73M4.91%
- Morgan Stanley - Brokerage Accounts5.31M4.55%
- Franklin Templeton Inc2.91M2.49%
- Vanguard Portfolio Management, LLC2.87M2.46%
- Geode Capital Management, LLC2.82M2.42%
- Massachusetts Financial Services Company2.45M2.10%
- FMR Inc2.13M1.83%
- JPMorgan Chase & Co1.75M1.50%
- AllianceBernstein L.P.1.69M1.45%
- Arrowstreet Capital Limited Partnership1.55M1.33%
- DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main1.54M1.32%
- NORGES BANK1.53M1.31%
- Northern Trust Corp1.44M1.24%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest3.82M3.28%
- Vanguard 500 Index Investor3.19M2.74%
- Fidelity 500 Index1.56M1.34%
- iShares Core S&P 500 ETF1.55M1.33%
- State Street® SPDR® S&P 500® ETF1.43M1.23%
Dividends
Stock Splits
- Jan 5, 19982:1